Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

ClinicalTrials.gov ID: NCT07284901

Public ClinicalTrials.gov record NCT07284901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 4, 2026, 11:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Study identification

NCT ID
NCT07284901
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kailera
Industry
Enrollment
1,700 participants

Conditions and interventions

Interventions

  • KAI-9531 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2026
Primary completion
Mar 26, 2028
Completion
Apr 23, 2028
Last update posted
Apr 29, 2026

2026 – 2028

United States locations

U.S. sites
31
U.S. states
22
U.S. cities
31
Facility City State ZIP Site status
Kailera Clinical Site Cullman Alabama 35055 Recruiting
Kailera Clinical Site Phoenix Arizona 85012 Recruiting
Kailera Clinical Site Sun City Arizona 85351 Recruiting
Kailera Clinical Site Little Rock Arkansas 72205 Recruiting
Kailera Clinical Site Escondido California 92025 Recruiting
Kailera Clinical Site Northridge California 91325 Recruiting
Kailera Clinical Site Oceanside California 92058 Recruiting
Kailera Clinical Site Toluca Lake California 91602 Recruiting
Kailera Clinical Site Stamford Connecticut 06905 Recruiting
Kailera Clinical Site Jupiter Florida 33458 Recruiting
Kailera Clinical Site Orange City Florida 32763 Recruiting
Kailera Clinical Site Lilburn Georgia 30047 Recruiting
Kailera Clinical Site Springfield Illinois 62702 Recruiting
Kailera Clinical Site Newton Kansas 67114 Recruiting
Kailera Clinical Site Shreveport Louisiana 71105 Recruiting
Kailera Clinical Site Columbia Maryland 21045 Recruiting
Kailera Clinical Site Missoula Montana 59804 Recruiting
Kailera Clinical Site Lincoln Nebraska 68516 Recruiting
Kailera Clinical Site Las Vegas Nevada 89148 Recruiting
Kailera Clinical Site Albany New York 12203 Recruiting
Kailera Clinical Site Greensboro North Carolina 27405 Recruiting
Kailera Clinical Site Morehead City North Carolina 28557 Recruiting
Kailera Clinical Site Chickasha Oklahoma 73018 Recruiting
Kailera Clinical Site Spartanburg South Carolina 29303 Recruiting
Kailera Clinical Site Chattanooga Tennessee 37405 Recruiting
Kailera Clinical Site Amarillo Texas 79124 Recruiting
Kailera Clinical Site Brownsville Texas 78526 Recruiting
Kailera Clinical Site DeSoto Texas 75115 Recruiting
Kailera Clinical Site Tomball Texas 77375 Recruiting
Kailera Clinical Site Salt Lake City Utah 84117 Recruiting
Kailera Clinical Site Richmond Virginia 23236 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07284901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07284901 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →